Aequus Pharmaceuticals (Aequus Pharmaceuticals) FCF Margin % : -989.74% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Aequus Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2024 was $-0.39 Mil. Aequus Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was $0.04 Mil. Therefore, Aequus Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was -989.74%.

As of today, Aequus Pharmaceuticals's current FCF Yield % is -35.79%.

The historical rank and industry rank for Aequus Pharmaceuticals's FCF Margin % or its related term are showing as below:

AQSZF' s FCF Margin % Range Over the Past 10 Years
Min: -1216.09 Med: -162.43 Max: -31.51
Current: -1216.09

During the past 11 years, the highest FCF Margin % of Aequus Pharmaceuticals was -31.51%. The lowest was -1216.09%. And the median was -162.43%.

AQSZF's FCF Margin % is ranked worse than
96.18% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 0.475 vs AQSZF: -1216.09

Aequus Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Aequus Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals FCF Margin % Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-99.92

-31.47

-43.33

-141.54

-900.00

Aequus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-116.31	-291.04	-	-1,768.42	-989.74

Competitive Comparison of Aequus Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aequus Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's FCF Margin % falls into.

Aequus Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Aequus Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.71	/	0.19
	=	-900.00 %

Aequus Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.386	/	0.039
	=	-989.74 %

Aequus Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals (Aequus Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AEQ:Germany AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.